Daisuke Funada
Kodaira, 1878551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Primary obsessive slowness in a young woman who benefited from continuous psychoeducation and modeling with video recordings during hospitalization: a case report.
Journal: BMC psychiatry
Published: November 03, 2023
Depression and suicidality with VMAT2 inhibitors in tardive dyskinesia A signal detection from the FDA Adverse Events Reporting System.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: July 12, 2022
Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography.
Journal: Frontiers in pharmacology
Published: November 23, 2021
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.
Journal: Neuropsychopharmacology reports
Published: June 11, 2021
Impact of COVID-19-related stress on methamphetamine users in Japan.
Journal: Psychiatry and clinical neurosciences
Published: March 09, 2021
Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis.
Journal: Psychiatry and clinical neurosciences
Published: October 26, 2020
Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders.
Journal: Neuropsychopharmacology reports
Published: May 04, 2020
Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
Journal: Neuropsychopharmacology reports
Published: November 09, 2018
Changes of clinical symptoms in patients with new psychoactive substance (NPS)-related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction.
Journal: Neuropsychopharmacology reports
Published: October 16, 2018
The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
Journal: Neuropsychopharmacology reports
Published: May 03, 2018
Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014.
Journal: Psychiatry and clinical neurosciences
Published: May 04, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026